Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ION537 |
| Synonyms | |
| Therapy Description |
ION537 is a YAP1 antisense oligonucleotide (ASO), which potentially reduces YAP1 expression resulting in reduced cell proliferation and inhibition of tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr ND11). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ION537 | ION 537|ION-537 | YAP Inhibitor 3 | ION537 is a YAP1 antisense oligonucleotide (ASO), which potentially reduces YAP1 expression resulting in reduced cell proliferation and inhibition of tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr ND11). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04659096 | Phase I | ION537 | A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors | Completed | USA | 0 |